REGISTERED NUMBER: SC245230 (Scotland)

Financial Statements for the Year Ended 31 March 2025

for

Kemnay Pharmacy Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Kenneth McDonald Manson

Mrs Lynn Iris Muriel Manson

Peter James Manson

Richard John Manson

SECRETARY:

Mrs Lynn Iris Muriel Manson

REGISTERED OFFICE:

18 North Silver Street

Aberdeen

AB10 1JU

REGISTERED NUMBER:

SC245230 (Scotland)

ACCOUNTANTS:

Tawse & Partners

Chartered Accountants

18 North Silver Street

Aberdeen

AB10 1JU

FIXED ASSETS

Intangible assets

5

945,611

1,210,584

Tangible assets

6

224,837

282,049

Investments

7

2,363,643

100

3,534,091

1,492,733

CURRENT ASSETS

Stocks

193,864

177,138

Debtors

8

1,169,923

1,398,274

Prepayments and accrued income

23,099

17,060

Cash at bank and in hand

1,049,910

1,242,498

2,436,796

2,834,970

CREDITORS

Amounts falling due within one year

9

1,186,524

1,124,967

NET CURRENT ASSETS

1,250,272

1,710,003

TOTAL ASSETS LESS CURRENT LIABILITIES

4,784,363

3,202,736

CREDITORS

Amounts falling due after more than one year

10

(3,762,180

)

(2,319,238

)

PROVISIONS FOR LIABILITIES

(54,950

)

(64,387

)

NET ASSETS

967,233

819,111

CAPITAL AND RESERVES

Called up share capital

12

2

2

Retained earnings

967,231

819,109

SHAREHOLDERS' FUNDS

967,233

819,111

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 November 2025 and were signed on its behalf by:

Kenneth McDonald Manson - Director

1.	STATUTORY INFORMATION

Kemnay Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

The company's principal place of business is High Street, Kemnay, Aberdeenshire, AB51 5NB, 187 North Deeside Road, Peterculter, AB14 0UJ and 359 North Deeside Road, Cults, Aberdeen, AB15 9SX.

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Accounting policies

The financial statements have been prepared under the historical cost convention.

The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year and have also been consistently applied within the same accounts.

Turnover recognition

Turnover is measured at fair value of the consideration received or receivable net of VAT and discounts. The policies adopted for the recognition of turnover are as follows:

Sale of goods

Turnover from the sale of goods is recognised when significant risks and rewards of ownership of the goods

have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

When the outcome of a transaction can be estimated reliably, turnover from services rendered is recognised by reference to the stage of completion at the Statement of Financial Position date. Stage of completion is measured by reference to the NHS Income Statements at the Statement of Financial Position date.

Grants receivable

Depending on the type of grant, the income is either recognised in the period it is received or in the same period as the costs it relates to.

Goodwill

Purchased goodwill is capitalised and depreciated on a straight line basis over its useful economic life (not exceeding 20 years).

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tenants improvements

-

Over term of lease

Plant and equipment

-

20% on reducing balance

Motor vehicles

-

25% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and estimated selling price less costs to sell. Cost includes all costs of purchases, costs of conversion and other costs incurred in bring stock to its present location and condition. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 41 (2024 - 36 ) .

5.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

2,934,728

AMORTISATION

At 1 April 2024

1,724,144

Amortisation for year

264,973

At 31 March 2025

1,989,117

NET BOOK VALUE

At 31 March 2025

945,611

At 31 March 2024

1,210,584

6.	TANGIBLE FIXED ASSETS

Tenants

Plant and

Motor

improvements

equipment

vehicles

Totals

£

£

£

£

COST

At 1 April 2024

2,083

513,988

30,345

546,416

Additions

-

3,471

-

3,471

At 31 March 2025

2,083

517,459

30,345

549,887

DEPRECIATION

At 1 April 2024

2,083

250,143

12,141

264,367

Charge for year

-

55,934

4,749

60,683

At 31 March 2025

2,083

306,077

16,890

325,050

NET BOOK VALUE

At 31 March 2025

-

211,382

13,455

224,837

At 31 March 2024

-

263,845

18,204

282,049

7.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 April 2024

100

Additions

2,363,543

At 31 March 2025

2,363,643

NET BOOK VALUE

At 31 March 2025

2,363,643

At 31 March 2024

100

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

386,441

481,564

Amounts owed by group undertakings

724,436

866,290

Other debtors

59,046

50,420

1,169,923

1,398,274

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans and overdrafts

336,692

174,506

Trade creditors

581,100

577,740

Taxation and social security

11,346

12,999

Other creditors

257,386

359,722

1,186,524

1,124,967

10.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans

3,762,180

2,319,238

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

2,391,760

1,598,477

11.	SECURED DEBTS

The following secured debts are included within creditors:

31.3.25

31.3.24

£

£

Bank loans

4,098,872

2,493,744

The banks holds a floating charge over the properties and the undertaking of the company.

12.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.25

31.3.24

value:

£

£

100

Ordinary Shares

£0.02

2

2